Table 3:
Postoperative Changes in Hypertension Severity (n=128)
| Baseline | Y1 | Y3 | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Variables | Male (n=77) | Female (n=51) | Male (n=77) | Female (n=51) | Male (n=77) | Female (n=51) |
| Blood pressure data | ||||||
| Systolic blood pressure, mmHg | 148±21 | 139±22 | 138±16 | 133±14 | 134±21 | 132±23 |
| Diastolic blood pressure, mmHg | 91±14 | 83±13 | 80±13 | 76±11 | 78±14 | 75±15 |
| Hypertension severity group | ||||||
| Normal blood pressure | 0 | 1 (2%) | 5 (7%) | 3 (6%) | 5 (7%) | 3 (6%) |
| Elevated blood pressure | 15 (20%) | 8 (16%) | 14 (18%) | 9 (18%) | 14 (18%) | 12 (24%) |
| Stage 1 hypertension | 19 (25%) | 14 (28%) | 46 (60%) | 26 (51%) | 46 (60%) | 29 (57%) |
| Stage 2 hypertension | 46 (60%) | 25 (49%)* | 16 (21%) | 9 (18%) | 19 (15%) | 19 (15%) |
| Intensity of therapy | ||||||
| Any anti-hypertensive medication | 68 (88%) | 40 (78%)* | 55 (71%) | 35 (69%) | 54 (70%) | 40 (78%) |
| 1 anti-hypertensive medication | 36 (47%) | 22 (43%) | 29 (38%) | 20 (39%) | 31 (40%) | 23 (45%) |
| 2 anti-hypertensive medication | 27 (35%) | 15 (29%)* | 26 (34%) | 15 (29%) | 25 (33%) | 15 (29%) |
| ≥3 anti-hypertensive medications | 5 (7%) | 3 (6%) | --- | --- | --- | --- |
| Anti-hypertensive therapy | ||||||
| Thiazide diuretics | 12 (16%) | 10 (20%) | 14 (14%) | 8 (16%) | 14 (14%) | 8 (16%) |
| Beta blockers | 37 (48%) | 21 (41%) | 16 (21%) | 12 (24%) | 16 (21%) | 11 (20%) |
| ACEI/ARB | 36 (47%) | 17 (33%)* | 26 (33%) | 16 (31%) | 26 (34%) | 15 (30%) |
| Calcium channel blockers | 25 (33%) | 13 (26%) | 12 (16%) | 7 (14%) | 13 (19%) | 10 (20%) |
| Hydralazine | 2 (3%) | 2 (4%) | --- | --- | --- | --- |
: Angiotensin converting enzyme inhibitor; ARB: Angiotensin-II receptor blockers;
*
signifies p value <0.05